NEW YORK (360Dx) – Qiagen said today that its QuantiFeron-TB Gold Plus (QFT-Plus) blood test for detecting latent tuberculosis infection has received US Food and Drug Administration approval.

Qiagen submitted the test to FDA in a pre-market approval supplement in late 2016, and the company said that it expects to begin marketing the assay in the US later this year.